Latest News
Elegant Hotels appoints Jeffrey Singleton interim CFO
AIM-listed Elegant Hotels Group has appointed industry veteran Jeffrey Singleton as interim chief financial officer with immediate effect.
London open: Stocks little changed as Gilts see small bounce
Stocks were little changed in early trading, following the excitement of the last few sessions and a big move higher for the Footsie on Thursday, as traders were increasingly eyeing the upcoming close of the year which typically results in calm trading conditions amid thin trading volumes.
Europe open: Stocks little changed; Actelion surges on Sanofi deal talk
European stocks were flat in quiet trade after Thursday’s session saw investors react to rate announcements from the Federal Reserve and the Bank of England.
Rentokil announces Workwear and Hygiene JV with Haniel
Rentokil Initial has agreed to merge its Workwear and Hygiene divisions with Germany's Haniel & Cie Holding Co.
Actavis accused of overcharging NHS for lifesaving drug
The Competition and Markets Authority has accused pharmaceutical company Actavis UK – formerly Auden Mckenzie – of breaking competition law by overcharging the NHS for hydrocortisone tablets.
US close: Stocks bounce back as bond yields steady, dollar jumps
Wall Street bounced back as US government bond yields steadied following the previous day's losses, with the rest of global capital markets playing catch-up.
IP Group gobbles up Parkwalk for £10m
Developer of intellectual property-based businesses IP Group announced on Friday that it has agreed to acquire Parkwalk Advisors, the UK's leading university spin-out focused EIS fund manager, for an initial consideration of £10m.
Balfour Beatty sells 80% stake in five street lighting projects
Construction company Balfour Beatty has sold its 80% stake in five street lighting private finance initiatives to funds managed by Equitix, an investment firm, for £33m.
Polar Capital outperforms benchmark at half-year stage
Polar Capital Technology Trust reported a 41. 2% increase in net assets to £1. 13bn at the half-year stage.
London pre-open: Stocks set for muted start
London stocks were set to nudge just a touch higher at the open, with a much quieter day on the cards after Thursday’s session saw investors react to rate announcements from the Federal Reserve and the Bank of England.
Friday newspaper round-up: Reckitt Benckiser, workers' pay, Brexit bill
The manufacturer of Nurofen has been fined $6m for misleading consumers. The federal court increased the penalty from $1. 7m to $6m after an appeal by the Australian Competition and Consumer Commission. In December 2015 the federal court found the British company Reckitt Benckiser, the manufacturer of the painkiller, had engaged in “misleading conduct” by representing that its Nurofen Specific Pain products targeted a type or area of pain despite being identical, and ordered they be removed from supermarket shelves within three months.